AU2002245257A1 - Srebp pathway modulation through targeting hisrs - Google Patents
Srebp pathway modulation through targeting hisrsInfo
- Publication number
- AU2002245257A1 AU2002245257A1 AU2002245257A AU2002245257A AU2002245257A1 AU 2002245257 A1 AU2002245257 A1 AU 2002245257A1 AU 2002245257 A AU2002245257 A AU 2002245257A AU 2002245257 A AU2002245257 A AU 2002245257A AU 2002245257 A1 AU2002245257 A1 AU 2002245257A1
- Authority
- AU
- Australia
- Prior art keywords
- hisrs
- targeting
- srebp pathway
- pathway modulation
- modulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Child & Adolescent Psychology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26156901P | 2001-01-12 | 2001-01-12 | |
US60/261,569 | 2001-01-12 | ||
PCT/US2002/001045 WO2002055663A2 (en) | 2001-01-12 | 2002-01-11 | Srebp pathway modulation through targeting hisrs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002245257A1 true AU2002245257A1 (en) | 2002-07-24 |
Family
ID=22993896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002245257A Abandoned AU2002245257A1 (en) | 2001-01-12 | 2002-01-11 | Srebp pathway modulation through targeting hisrs |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1356079A4 (en) |
JP (1) | JP2004524021A (en) |
AU (1) | AU2002245257A1 (en) |
WO (1) | WO2002055663A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010013632A (en) | 2008-06-11 | 2011-06-16 | Atyr Pharma Inc | Thrombopoietic activity of tyrosyl-trna synthetase polypeptides. |
JP5756751B2 (en) | 2008-06-26 | 2015-07-29 | エータイアー ファーマ, インコーポレイテッド | Compositions and methods comprising glycyl-tRNA synthetase with non-canonical biological activity |
ES2552773T3 (en) | 2009-02-27 | 2015-12-02 | Atyr Pharma, Inc. | Structural reasons for polypeptides associated with cell signaling activity |
AU2010226726B8 (en) | 2009-03-16 | 2014-08-14 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities |
CN102449143B (en) | 2009-03-31 | 2017-11-14 | Atyr医药公司 | Include the composition and method of the aspartoyl tRNA synzyme with unconventional bioactivity |
EP2939689B1 (en) | 2009-12-11 | 2017-09-13 | aTyr Pharma, Inc. | Glutaminyl tRNA synthetases for use in the treatment of inflammatory disorders |
US8828395B2 (en) | 2009-12-11 | 2014-09-09 | Atyr Pharma, Inc. | Antibodies that bind tyrosyl-tRNA synthetases |
CA2804278C (en) | 2010-07-12 | 2021-07-13 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
WO2012021249A2 (en) | 2010-07-12 | 2012-02-16 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
AU2011289831C1 (en) | 2010-07-12 | 2017-06-15 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
WO2012027611A2 (en) | 2010-08-25 | 2012-03-01 | Atyr Pharma, Inc. | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
WO2013022982A2 (en) | 2011-08-09 | 2013-02-14 | Atyr Pharma, Inc. | Pegylated tyrosyl-trna synthetase polypeptides |
US9822353B2 (en) | 2011-12-06 | 2017-11-21 | Atyr Pharma, Inc. | PEGylated aspartyl-tRNA synthetase polypeptides |
WO2013086216A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Improved aspartyl-trna synthetases |
CA2858613A1 (en) | 2011-12-29 | 2013-08-08 | Atyr Pharma, Inc. | Aspartyl-trna synthetase-fc conjugates |
WO2013123432A2 (en) | 2012-02-16 | 2013-08-22 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
CN105378075B (en) | 2013-03-15 | 2022-04-05 | Atyr 医药公司 | Histidyl-TRNA synthetase-FC conjugates |
WO2015027171A1 (en) * | 2013-08-23 | 2015-02-26 | Quintiles Transnational Corporation | Methods for predicting toxicity in response to treatment with a drug by assessing activation of the sterol regulatory binding protein (srebp) pathway |
JP2020517638A (en) | 2017-04-20 | 2020-06-18 | エータイアー ファーマ, インコーポレイテッド | Compositions and methods for treating lung inflammation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003501102A (en) * | 1999-06-14 | 2003-01-14 | エクセリクシス,インク | Animal models and methods for the analysis of lipid metabolism and the screening of pharmaceuticals and insecticides that regulate lipid metabolism |
-
2002
- 2002-01-11 AU AU2002245257A patent/AU2002245257A1/en not_active Abandoned
- 2002-01-11 WO PCT/US2002/001045 patent/WO2002055663A2/en not_active Application Discontinuation
- 2002-01-11 EP EP02713405A patent/EP1356079A4/en not_active Withdrawn
- 2002-01-11 JP JP2002556714A patent/JP2004524021A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002055663A3 (en) | 2002-09-19 |
EP1356079A4 (en) | 2005-10-19 |
JP2004524021A (en) | 2004-08-12 |
EP1356079A2 (en) | 2003-10-29 |
WO2002055663A2 (en) | 2002-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002245257A1 (en) | Srebp pathway modulation through targeting hisrs | |
EP1443963A4 (en) | Antibody targeting compounds | |
AU2002331756A1 (en) | Washpipe assembly | |
AU2002330998A1 (en) | Benzoquinone ansamycins | |
EP1446418A4 (en) | Integrin targeting compounds | |
AUPR419701A0 (en) | An improved backpack | |
AU2002366286A1 (en) | Microencapsulated insecticide | |
AU2002306859A1 (en) | Hybrid-imaging spectrometer | |
AU2002343312A1 (en) | Two fixed-beams tx-diversity | |
AU2001263208A1 (en) | Targeting fixture | |
AU2002354080A1 (en) | Photodiode | |
AU2002300272A1 (en) | Roadway Delimiting Means | |
AU2001279748A1 (en) | Herbicides | |
AU2002253142A1 (en) | Axle assembly | |
AU2001289902A1 (en) | Novel herbicides | |
AU2002354659A1 (en) | Solution influenced alignment | |
AU2002357512A1 (en) | Oscillator | |
AU2002356496A1 (en) | Dsp-18 dual-specificity phosphatase | |
AU2002221613A1 (en) | Novel herbicides | |
AU2001100231A4 (en) | P2P community | |
AUPR316501A0 (en) | Herbicide | |
AUPR881501A0 (en) | Gap planter | |
AU2002302584A1 (en) | Substituted arylketones | |
AU2001242653A1 (en) | Self-propelled suitcase | |
AU2002339852A1 (en) | Application class extensions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |